Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe

A Luca; D Dunn; M Zazzi; R Camacho; C Torti; I Fanti; R Kaiser; A Sonnerborg; FM Codoner; K Van Laethem; AM Vandamme; L Bansi; V Ghisetti; David van de Vijver; D Asboe; MCF Prosperi; S Di Giambenedetto

doi:10.1093/infdis/jit017

Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe

A Luca
, D Dunn
, M Zazzi
, R Camacho
, C Torti
, I Fanti
, R Kaiser
, A Sonnerborg
, FM Codoner
, K Van Laethem
, AM Vandamme
, L Bansi
, V Ghisetti
, David van de Vijver
, D Asboe
, MCF Prosperi
, S Di Giambenedetto

Virology

Research output: Contribution to journal › Article › Academic › peer-review

60 Citations (Scopus)

Abstract

HIV-1 drug resistance represents a major obstacle to infection and disease control. This retrospective study analyzes trends and determinants of resistance in antiretroviral treatment (ART)-exposed individuals across 7 countries in Europe. Of 20 323 cases, 80% carried at least one resistance mutation: these declined from 81% in 1997 to 71% in 2008. Predicted extensive 3-class resistance was rare (3.2% considering the cumulative genotype) and peaked at 4.5% in 2005, decreasing thereafter. The proportion of cases exhausting available drug options dropped from 32% in 2000 to 1% in 2008. Reduced risk of resistance over calendar years was confirmed by multivariable analysis.

Original language	Undefined/Unknown
Pages (from-to)	1216-1220
Number of pages	5
Journal	Journal of Infectious Diseases
Volume	207
Issue number	8
DOIs	https://doi.org/10.1093/infdis/jit017
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MM-04-27-01

Access to Document

10.1093/infdis/jit017

http://hdl.handle.net/1765/64834

Cite this

Luca, A., Dunn, D., Zazzi, M., Camacho, R., Torti, C., Fanti, I., Kaiser, R., Sonnerborg, A., Codoner, FM., Van Laethem, K., Vandamme, AM., Bansi, L., Ghisetti, V., van de Vijver, D., Asboe, D., Prosperi, MCF., & Di Giambenedetto, S. (2013). Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe. Journal of Infectious Diseases, 207(8), 1216-1220. https://doi.org/10.1093/infdis/jit017

@article{fdea83243bf24a1c86c6f3ae715eb7e7,

title = "Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe",

abstract = "HIV-1 drug resistance represents a major obstacle to infection and disease control. This retrospective study analyzes trends and determinants of resistance in antiretroviral treatment (ART)-exposed individuals across 7 countries in Europe. Of 20 323 cases, 80\% carried at least one resistance mutation: these declined from 81\% in 1997 to 71\% in 2008. Predicted extensive 3-class resistance was rare (3.2\% considering the cumulative genotype) and peaked at 4.5\% in 2005, decreasing thereafter. The proportion of cases exhausting available drug options dropped from 32\% in 2000 to 1\% in 2008. Reduced risk of resistance over calendar years was confirmed by multivariable analysis.",

author = "A Luca and D Dunn and M Zazzi and R Camacho and C Torti and I Fanti and R Kaiser and A Sonnerborg and FM Codoner and \{Van Laethem\}, K and AM Vandamme and L Bansi and V Ghisetti and \{van de Vijver\}, David and D Asboe and MCF Prosperi and \{Di Giambenedetto\}, S",

year = "2013",

doi = "10.1093/infdis/jit017",

language = "Undefined/Unknown",

volume = "207",

pages = "1216--1220",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "8",

}

Luca, A, Dunn, D, Zazzi, M, Camacho, R, Torti, C, Fanti, I, Kaiser, R, Sonnerborg, A, Codoner, FM, Van Laethem, K, Vandamme, AM, Bansi, L, Ghisetti, V, van de Vijver, D, Asboe, D, Prosperi, MCF & Di Giambenedetto, S 2013, 'Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe', Journal of Infectious Diseases, vol. 207, no. 8, pp. 1216-1220. https://doi.org/10.1093/infdis/jit017

TY - JOUR

T1 - Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe

AU - Luca, A

AU - Dunn, D

AU - Zazzi, M

AU - Camacho, R

AU - Torti, C

AU - Fanti, I

AU - Kaiser, R

AU - Sonnerborg, A

AU - Codoner, FM

AU - Van Laethem, K

AU - Vandamme, AM

AU - Bansi, L

AU - Ghisetti, V

AU - van de Vijver, David

AU - Asboe, D

AU - Prosperi, MCF

AU - Di Giambenedetto, S

PY - 2013

Y1 - 2013

N2 - HIV-1 drug resistance represents a major obstacle to infection and disease control. This retrospective study analyzes trends and determinants of resistance in antiretroviral treatment (ART)-exposed individuals across 7 countries in Europe. Of 20 323 cases, 80% carried at least one resistance mutation: these declined from 81% in 1997 to 71% in 2008. Predicted extensive 3-class resistance was rare (3.2% considering the cumulative genotype) and peaked at 4.5% in 2005, decreasing thereafter. The proportion of cases exhausting available drug options dropped from 32% in 2000 to 1% in 2008. Reduced risk of resistance over calendar years was confirmed by multivariable analysis.

AB - HIV-1 drug resistance represents a major obstacle to infection and disease control. This retrospective study analyzes trends and determinants of resistance in antiretroviral treatment (ART)-exposed individuals across 7 countries in Europe. Of 20 323 cases, 80% carried at least one resistance mutation: these declined from 81% in 1997 to 71% in 2008. Predicted extensive 3-class resistance was rare (3.2% considering the cumulative genotype) and peaked at 4.5% in 2005, decreasing thereafter. The proportion of cases exhausting available drug options dropped from 32% in 2000 to 1% in 2008. Reduced risk of resistance over calendar years was confirmed by multivariable analysis.

U2 - 10.1093/infdis/jit017

DO - 10.1093/infdis/jit017

M3 - Article

C2 - 23315324

SN - 0022-1899

VL - 207

SP - 1216

EP - 1220

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

IS - 8

ER -